CVAP-B protocol

chemotherapy protocol consisting of above 5 cpds

Also Known As:

CVAP-Bleo

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CVAP-B protocol: 1
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CVAP-B protocol: 1
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CVAP-B protocol: 1
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Teniposide: 573
      - CVAP-B protocol: 1
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - CVAP-B protocol: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - CVAP-B protocol: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        CVAP-B protocol: 1
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        CVAP-B protocol: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        Cytarabine: 6662
        CVAP-B protocol: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        CVAP-B protocol: 1
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - CVAP-B protocol: 1
Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Prednisolone: 12013
        CVAP-B protocol: 1

Related Diseases

1.	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/08/1983 - "Sixty-two patients with aggressive non-Hodgkin's lymphoma (diffuse mixed, diffuse large cells, non-cleaved small cells (Burkitt-like), immunoblastic, lymphoblastic and other non-epidermotropic T lymphomas) were treated by intensive sequential chemotherapy combining heavy induction treatment (modified CHOP-Bleo), sequential consolidation treatment (cytosine arabinoside and thioguanine, then high-dose methotrexate and L-asparaginase) and final reinforcement (CVAP-Bleo). "
2.	Lymphoma (Lymphomas) 10/08/1983 - "Sixty-two patients with aggressive non-Hodgkin's lymphoma (diffuse mixed, diffuse large cells, non-cleaved small cells (Burkitt-like), immunoblastic, lymphoblastic and other non-epidermotropic T lymphomas) were treated by intensive sequential chemotherapy combining heavy induction treatment (modified CHOP-Bleo), sequential consolidation treatment (cytosine arabinoside and thioguanine, then high-dose methotrexate and L-asparaginase) and final reinforcement (CVAP-Bleo). "

Related Drugs and Biologics

1.	Thioguanine (Tioguanine)
2.	Methotrexate (Mexate)
3.	Cytarabine (Cytosar-U)
4.	Asparaginase (Elspar)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	CHOP-B protocol